Minnesota Defends Drug Price Law in Appeal of Lower Court Pause

A federal appeals court ruling against a Minnesota drug pricing law could open the door to litigation questioning the state’s authority to regulate medicines within its borders, a state attorney said in oral arguments Wednesday.

The law, which allows Minnesota to impose penalties on generic drug manufacturers for excessive price increases, falls under the state’s regulatory scheme that drugmakers agree to comply with when they license to sell their drugs within the state, Assistant Attorney General Nicholas J. Pladson argued on behalf of Minnesota Attorney General Keith Ellison (D) before a three-judge panel at the US Court of Appeals for ...